WO2010106555A3 - Directly compressible pre-granulated cellulose ether polymer and process for preparing the same - Google Patents

Directly compressible pre-granulated cellulose ether polymer and process for preparing the same Download PDF

Info

Publication number
WO2010106555A3
WO2010106555A3 PCT/IN2010/000157 IN2010000157W WO2010106555A3 WO 2010106555 A3 WO2010106555 A3 WO 2010106555A3 IN 2010000157 W IN2010000157 W IN 2010000157W WO 2010106555 A3 WO2010106555 A3 WO 2010106555A3
Authority
WO
WIPO (PCT)
Prior art keywords
ether polymer
directly compressible
cellulose ether
preparing
same
Prior art date
Application number
PCT/IN2010/000157
Other languages
French (fr)
Other versions
WO2010106555A2 (en
Inventor
Amin Purnima Dhanraj
Shah Sejal Pravin
Jain Satishkumar Pannalal
Pirthi Pal Singh Partap Singh
Sawant Kiran Parshuram
Original Assignee
Shantilal, Doshi, Bimalkumar
Chandrakumar, Shah, Gautam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shantilal, Doshi, Bimalkumar, Chandrakumar, Shah, Gautam filed Critical Shantilal, Doshi, Bimalkumar
Publication of WO2010106555A2 publication Critical patent/WO2010106555A2/en
Publication of WO2010106555A3 publication Critical patent/WO2010106555A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

The present invention relates to the process for preparing the pre-granulated directly compressible cellulose ether polymer granular assemblies. The present invention further provides the pre-granulated directly compressible cellulose ether polymer granular assemblies, composition comprising pre-granulated directly compressible cellulosic ether polymer granular assemblies and an active constituent and dosage forms prepared by the direct compression of the composition comprising a pre-granulated directly compressible cellulosic ether polymer granular assemblies and an active constituent.
PCT/IN2010/000157 2009-03-17 2010-03-17 Directly compressible pre-granulated cellulose ether polymer and process for preparing the same WO2010106555A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN572MU2009 2009-03-17
IN572MUM/2009 2009-03-17
IN226/MUM/2010 2010-01-28
IN226MU2010 2010-01-28

Publications (2)

Publication Number Publication Date
WO2010106555A2 WO2010106555A2 (en) 2010-09-23
WO2010106555A3 true WO2010106555A3 (en) 2011-03-10

Family

ID=42740077

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000157 WO2010106555A2 (en) 2009-03-17 2010-03-17 Directly compressible pre-granulated cellulose ether polymer and process for preparing the same

Country Status (1)

Country Link
WO (1) WO2010106555A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8992987B2 (en) 2011-04-06 2015-03-31 Dow Global Technologies Llc Polysaccharide derivatives and dosage forms
CN112592311B (en) * 2021-01-03 2023-01-31 迪沙药业集团有限公司 Nifedipine A crystal block crystal habit and controlled release tablet composition thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119192A1 (en) * 2000-09-22 2002-08-29 Vishwanathan Narayanan Badri Controlled release formulations for oral administration
US20050147673A1 (en) * 1996-06-10 2005-07-07 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible sustained release formulation containing microcrystalline cellulose
US20050250838A1 (en) * 2004-05-04 2005-11-10 Challapalli Prasad V Formulation for sustained delivery
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology
US20080081068A1 (en) * 2005-06-27 2008-04-03 Biovail Laboratories International S.R.L. Modified release formulations of a bupropion salt
US20080182908A1 (en) * 2007-01-25 2008-07-31 Vinita Umashankar Vyas Pharmaceutical compositions comprising memantine

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050147673A1 (en) * 1996-06-10 2005-07-07 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible sustained release formulation containing microcrystalline cellulose
US20020119192A1 (en) * 2000-09-22 2002-08-29 Vishwanathan Narayanan Badri Controlled release formulations for oral administration
US20050250838A1 (en) * 2004-05-04 2005-11-10 Challapalli Prasad V Formulation for sustained delivery
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology
US20080081068A1 (en) * 2005-06-27 2008-04-03 Biovail Laboratories International S.R.L. Modified release formulations of a bupropion salt
US20080182908A1 (en) * 2007-01-25 2008-07-31 Vinita Umashankar Vyas Pharmaceutical compositions comprising memantine

Also Published As

Publication number Publication date
WO2010106555A2 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
PH12017502223A1 (en) A novel water dispersible granular composition
FI20095800A0 (en) Nonwoven composite product with high cellulose content
MX2008011579A (en) Divisible dosage form allowing modified release of the active principle.
EP2210591A3 (en) Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
WO2011143632A3 (en) Cellobiohydrolase variants
WO2010049454A3 (en) Antimicrobial composition from copepods
MX350447B (en) A fast dissolving pharmaceutical composition.
CL2011002041A1 (en) Compounds derived from 4-isopropylphenylglucitol, sglt1 inhibitors; pharmaceutical preparation; and its use as an agent to improve postprandial hyperglycemia and as a prophylactic or therapeutic agent for diabetes.
BRPI0913441A8 (en) PREBIOTICS COMPOSITION AND METHODS OF PRODUCTION AND USE OF THE SAME
MX2012007244A (en) Flavor-enriching agent.
WO2007131795A3 (en) Carbon granules, process for producing them and their use
MX337357B (en) Lactose and cellulose-based tableting aid.
WO2012011758A3 (en) Apparatus for dehydrating filter press
JO3112B1 (en) A fast dissolving pharmaceutical composition
WO2010119102A3 (en) Pharmaceutical composition containing proton pump inhibitor for treating dermatological autoimmune diseases
MY157155A (en) Method for enhancing efficacy of agrichemical, and agrichemical-containing composition
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
PL1994926T3 (en) Valsartan formulations
WO2010106555A3 (en) Directly compressible pre-granulated cellulose ether polymer and process for preparing the same
MX2011006721A (en) Pharmaceutical formulation of nanonised fenofibrate.
WO2011003603A3 (en) Composition for the production of tablets, and method for the production of said composition
EA201170843A1 (en) PRELIMINARYLY COMPRESSED QUICKLY DECOMPOSING MEDICINAL FORMS OF COMPOUNDS WITH LOW ORAL BIODUSABILITY
WO2012016646A9 (en) Quetiapine tablets
WO2012147094A8 (en) Method and system for extraction of black liquor from a horizontal tube continuous digester
WO2012150607A3 (en) Oral liquid composition comprising divalproex sodium and process for preparing thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10753215

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 23.11.11)

122 Ep: pct application non-entry in european phase

Ref document number: 10753215

Country of ref document: EP

Kind code of ref document: A2